Corebridge Financial’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-58,606
Closed -$2.5M 1099
2025
Q1
$2.5M Sell
58,606
-66
-0.1% -$2.85K 0.01% 906
2024
Q4
$1.79M Sell
58,672
-4,428
-7% -$125K 0.01% 1061
2024
Q3
$1.45M Sell
63,100
-389
-0.6% -$11K 0.01% 1183
2024
Q2
$1.83M Buy
+63,489
New +$1.48M 0.01% 1047

Other funds holding GH

Corebridge Financial's GH Position: Q2 2025 in Review

Corebridge Financial sold out of Guardant Health (GH) in Q2 2025, closing a stake of 58,606 shares — an estimated $2.5M sold.

Corebridge Financial first reported a position in GH in Q2 2024 and held it in 4 quarters. The position peaked at $2.5M in Q1 2025. 365 funds tracked by Wall St. Rank hold GH as of Q2 2025.

  • Corebridge Financial reported no remaining Guardant Health position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 58,606 Guardant Health shares in Q2 2025, an estimated $2.5M.
  • Corebridge Financial first reported a position in Guardant Health in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Guardant Health position peaked at $2.5M in Q1 2025.
  • 365 funds tracked by Wall St. Rank held Guardant Health as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.